journal article·2025-02-13

Synthesis of Magnetic Nanoparticles Coated with Human Serum Albumin and Loaded by Doxorubicin

Kirill Petrov, Elena Ryabova, Elena Dmitrienko, Alexey Chubarov

Magnetochemistry· Volume 11· Issue 2
Publisher page

Abstract

Magnetic iron oxide (II,III) nanoparticles (MNPs) are highly interested in biomedicine. However, their application is limited by oxidation, aggregation, rapid clearance from the body, and poor biodistribution. Coating by human serum albumin (HSA), the predominant blood plasma protein, can significantly influence properties, prolong circulation half-life, and enhance tumor capture efficiency. Here, we report the synthesis of oleic acid and Tween20-coated MNPs and their interaction with HSA. The influence of albumin coating on MNP size, zeta potential, aggregation ability, and toxicity was studied. The particles were characterized by dynamic light scattering, transmission electron microscopy, and Fourier transform infrared spectroscopy methods. The nanoparticles’ relaxivities (r1 and r2) were assessed under a magnetic field of 1.88 T to evaluate their performance in MRI applications. The anticancer drug doxorubicin (DOX) loading capacity of up to 725 µg/mg for albumin-coated MNPs was determined. DOX-loaded MNPs displayed pH-sensitive drug release during acidic conditions. The series of DOX-loaded nanocomposites indicated inhibition of A549 cell lines, and the IC50 values were evaluated. This research underscores the utility of HSA-coated MNPs in enhancing the efficacy and stability of drug delivery systems in biomedicine.
Source: crossref · Quality: baseline

Research context

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Chemical Biology and Fundamental Medicine SB RAS, 630090 Novosibirsk, Russia

Funding

Russian state-funded project for ICBFM SB RAS

References (85)

Show source-provided references
1. Ali, A., Shah, T., Ullah, R., Zhou, P., Guo, M., Ovais, M., Tan, Z., and Rui, Y.K. (2021). Review on Recent Progress in Magnetic Nanoparticles: Synthesis, Characterization, and Diverse Applications. Front. Chem., 9.10.3389/fchem.2021.629054 ↗
2. Recent Progress of Magnetic Nanoparticles in Biomedical Applications: A Review10.1002/nano.202000162 ↗
3. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering10.1021/acsabm.0c00947 ↗
4. Schneider, M.G.M., Martín, M.J., Otarola, J., Vakarelska, E., Simeonov, V., Lassalle, V., and Nedyalkova, M. (2022). Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives. Pharmaceutics, 14.10.3390/pharmaceutics14010204 ↗
5. Tran, H., Ngo, N.M., Medhi, R., Srinoi, P., Liu, T., Rittikulsittichai, S., and Lee, T.R. (2022). Multifunctional Iron Oxide Magnetic Nanoparticles for Biomedical Applications: A Review. Materials, 15.10.3390/ma15020503 ↗
6. Biochemical and Biophysical Research Communications Multifunctional Carbon Nanomaterial Hybrids for Magnetic Manipulation and Targeting10.1016/j.bbrc.2015.06.131 ↗
7. Stimuli-Responsive Magnetic Nanomicelles as Multifunctional Heat and Cargo Delivery Vehicles10.1021/la3044158 ↗
8. The Regulation of Iron Absorption and Homeostasis
9. Oxidation of Magnetite Nanoparticles: Impact on Surface and Crystal Properties10.1039/C6CE02421A ↗
10. Zhu, N., Ji, H., Yu, P., Niu, J., Farooq, M.U., Akram, M.W., Udego, I.O., Li, H., and Niu, X. (2018). Surface Modification of Magnetic Iron Oxide Nanoparticles. Nanomaterials, 8.10.3390/nano8100810 ↗
11. Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field10.1186/s11671-020-03344-7 ↗
12. Minireview: Nanoparticles and the Immune System10.1210/en.2009-1082 ↗
13. Recent Progress in the Effect of Magnetic Iron Oxide Nanoparticles on Cells and Extracellular Vesicles10.1038/s41420-023-01490-2 ↗
14. Malhotra, N., Lee, J.S., Liman, R.A.D., Ruallo, J.M.S., Villaflore, O.B., Ger, T.R., and Hsiao, C. (2020). Der Potential Toxicity of Iron Oxide Magnetic Nanoparticles: A Review. Molecules, 25.10.3390/molecules25143159 ↗
15. Analysis of Nanoparticle Delivery to Tumours10.1038/natrevmats.2016.14 ↗
16. Portilla, Y., Afonso, Y.F., Yagüe, S.P., Arias, V.M., Morales, M.P., Gutiérrez, L., and Barber, D.F. (2023). Different Coatings on Magnetic Nanoparticles Dictate Their Degradation Kinetics in Vivo for 15 Months after Intravenous Administration in Mice. J. Nanobiotechnol., 20.10.1186/s12951-022-01747-5 ↗
17. Comanescu, C. (2023). Recent Advances in Surface Functionalization of Magnetic Nanoparticles. Coatings, 13.10.3390/coatings13101772 ↗
18. Meng, Y.Q., Shi, Y.N., Zhu, Y.P., Liu, Y.Q., Gu, L.W., Liu, D.D., Ma, A., and Xia, F. (2024). Recent Trends in Preparation and Biomedical Applications of Iron Oxide Nanoparticles. J. Nanobiotechnol., 22.10.1186/s12951-023-02235-0 ↗
19. Popova, V., Dmitrienko, E., and Chubarov, A. (2023). Magnetic Nanocomposites and Imprinted Polymers for Biomedical Applications of Nucleic Acids. Magnetochemistry, 9.10.3390/magnetochemistry9010012 ↗
20. Chubarov, A.S. (2022). Serum Albumin for Magnetic Nanoparticles Coating. Magnetochemistry, 8.10.3390/magnetochemistry8020013 ↗
21. Human Serum Albumin: From Bench to Bedside10.1016/j.mam.2011.12.002 ↗
22. The Development of Human Serum Albumin-Based Drugs and Relevant Fusion Proteins for Cancer Therapy10.1016/j.ijbiomac.2021.07.080 ↗
23. Otagiri, M., and Chuang, V.T.G. (2016). Human Serum Albumin: A Multifunctional Protein. Albumine in Medicine, Springer.10.1007/978-981-10-2116-9 ↗
24. Recent Progress in Drug Delivery System for Cancer Therapy Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System10.1248/cpb.c20-00026 ↗
25. Tumor Abnormality-Oriented Nanomedicine Design10.1021/acs.chemrev.3c00062 ↗
26. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise10.1002/adma.201600038 ↗
27. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery10.1021/acs.molpharmaceut.1c00046 ↗
28. Merlot, A.M., Kalinowski, D.S., and Richardson, D.R. (2014). Unraveling the Mysteries of Serum Albumin—More than Just a Serum Protein. Front. Physiol., 5.10.3389/fphys.2014.00299 ↗
29. HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy10.1021/mp200006f ↗
30. Ostroverkhov, P., Semkina, A., Naumenko, V., Plotnikova, E., Yakubovskaya, R., Vodopyanov, S., Abakumov, A., and Majouga, A. (2018). HSA—Coated Magnetic Nanoparticles for MRI-Guided Photodynamic Cancer Therapy. Pharmaceutics, 10.10.3390/pharmaceutics10040284 ↗
31. Ultrasmall Superparamagnetic Iron Oxide Nanoparticle for T2-Weighted Magnetic Resonance Imaging10.1021/acsami.7b10030 ↗
32. Sharma, I., Pawar, A., Milley, A., and Unsworth, L.D. (2024). Hemocompatibility of Albumin-Modified Magnetic Nanoparticles. Int. J. Mol. Sci., 25.10.3390/ijms252211975 ↗
33. Albumin Corona on Nanoparticles—A Strategic Approach in Drug Delivery10.3109/10717544.2015.1048488 ↗
34. Preformed Albumin Corona, a Protective Coating for Nanoparticles Based Drug Delivery System10.1016/j.biomaterials.2013.07.102 ↗
35. Preparation of a Highly Stable Drug Carrier by Efficient Immobilization of Human Serum Albumin (HSA) on Drug-Loaded Magnetic Iron Oxide Nanoparticles10.1016/j.ijbiomac.2018.12.143 ↗
36. Enhanced Biostability of Nanoparticle-Based Drug Delivery Systems by Albumin Corona10.2217/nnm.14.86 ↗
37. Pondman, K., and Kishore, U. (2023). Immunobiology Nanoparticle-Induced Immune Response: Health Risk versus Treatment Opportunity?. Immunobiology, 228.10.1016/j.imbio.2022.152317 ↗
38. Cytotoxicity,Intracellular Distribution and Uptake of Doxorubicin and Doxorubicin Coupled to Cell-Penetrating Peptides in Different Cell Lines: A Comparative Study10.1016/j.bbrc.2009.11.073 ↗
39. A Review of the Pathophysiological Mechanisms of Doxorubicin-Induced Cardiotoxicity and Aging10.1038/s41514-024-00135-7 ↗
40. Review DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs10.1016/j.chembiol.2010.04.012 ↗
41. Ibrahim, M., Abuwatfa, W.H., Awad, N.S., and Sabouni, R. (2022). Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review. Pharmaceutics, 14.10.3390/pharmaceutics14020254 ↗
42. Angelo, N.A.D., Noronha, M.A., Câmara, M.C.C., Kurnik, I.S., Feng, C., Araujo, V.H.S., Santos, J.H.P.M., Feitosa, V., Molino, J.V.D., and Rangel-yagui, C.O. (2022). Biomaterials Advances Doxorubicin Nanoformulations on Therapy against Cancer: An Overview from the Last 10 Years. Biomater. Adv., 133.10.1016/j.msec.2021.112623 ↗
43. Doxorubicin-Loaded Composite Nanogels for Cancer Treatment10.1016/j.jconrel.2020.08.033 ↗
44. Nanomaterials as an Advanced Nano-Tool for the Doxorubicin Delivery/Co-Delivery—A Comprehensive Review10.1016/j.jddst.2023.104432 ↗
45. Zhuo, S., Zhang, F., Yu, J., Zhang, X., and Yang, G. (2020). PH-Sensitive Biomaterials for Drug Delivery. Molecules, 25.10.3390/molecules25235649 ↗
46. Kovrigina, E., Chubarov, A., and Dmitrienko, E. (2022). High Drug Capacity Doxorubicin-Loaded Iron Oxide Nanocomposites for Cancer Therapy. Magnetochemistry, 8.10.3390/magnetochemistry8050054 ↗
47. Triplet Fullerenes as Prospective Spin Labels for Nanoscale Distance Measurements by Pulsed Dipolar EPR10.1002/anie.201904152 ↗
48. Design of Protein Homocystamides with Enhanced Tumor Uptake Properties for 19F Magnetic Resonance Imaging10.1016/j.bmc.2015.09.043 ↗
49. Popova, V., Poletaeva, Y., Chubarov, A., and Dmitrienko, E. (2023). PH-Responsible Doxorubicin-Loaded Fe3O4@CaCO3 Nanocomposites for Cancer Treatment. Pharmaceutics, 15.10.3390/pharmaceutics15030771 ↗
50. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays10.1016/0022-1759(83)90303-4 ↗
51. Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results10.1021/acs.langmuir.1c02056 ↗
52. Kovrigina, E., Poletaeva, Y., Zheng, Y., and Chubarov, A. (2023). Nylon-6-Coated Doxorubicin-Loaded Magnetic Nanoparticles and Nanocapsules for Cancer Treatment. Magnetochemistry, 9.10.3390/magnetochemistry9040106 ↗
53. Synthesis of Oleic Acid Coated Iron Oxide Nanoparticles and Its Role in Anti-Biofilm Activity against Clinical Isolates of Bacterial Pathogens10.1016/j.jtice.2015.07.018 ↗
54. Microcurrent Cloth-Assisted Transdermal Penetration and Follicular Ducts Escape of Curcumin-Loaded Micelles for Enhanced Wound Healing10.2147/IJN.S440034 ↗
55. Synthesis and Characterization of Magnetite/PLGA/Chitosan Nanoparticles10.1088/2053-1591/2/9/095010 ↗
56. Environmental Nanotechnology, Monitoring & Management Microwave Assisted Synthesis of Oleic Acid Modified Magnetite Nanoparticles for Benzene Adsorption
57. Physicochemical Characterization of Sodium Stearoyl Lactylate (SSL), Polyoxyethylene Sorbitan Monolaurate (Tween 20) and κ-Carrageenan10.1016/j.dib.2018.05.064 ↗
58. A Novel Two-Step Modifying Process for Preparation of Chitosan-Coated Fe3O4/SiO2 Microspheres10.1016/j.jmatprotec.2008.07.044 ↗
59. Synthesis, Surface Modification and Characterisation of Biocompatible Magnetic Iron Oxide Nanoparticles for Biomedical Applications10.3390/molecules18077533 ↗
60. Water Dispersible Oleic Acid-Coated Fe3O4 Nanoparticles for Biomedical Applications10.1016/j.jmmm.2014.10.137 ↗
61. Non-Aqueous to Aqueous Phase Transfer of Oleic Acid Coated Iron Oxide Nanoparticles for Hyperthermia Application10.1039/C3RA44644A ↗
62. Ultra-Small Fatty Acid-Stabilized Magnetite Nanocolloids Synthesized by In Situ Hydrolytic Precipitation10.1155/2015/620672 ↗
63. Baki, A., Remmo, A., Löwa, N., Wiekhorst, F., and Bleul, R. (2021). Albumin-Coated Single-Core Iron Oxide Nanoparticles for Enhanced Molecular Magnetic Imaging (MRI/MPI). Int. J. Mol. Sci., 22.10.3390/ijms22126235 ↗
64. BSA-Coated Magnetic Nanoparticles for Improved Therapeutic Properties10.1039/C5TB00833F ↗
65. Nanoencapsulation of Ultra-Small Superparamagnetic Particles of Iron Oxide into Human Serum Albumin Nanoparticles10.3762/bjnano.5.235 ↗
66. Protein-Passivated Fe3O4 Nanoparticles: Low Toxicity and Rapid Heating for Thermal Therapy10.1039/b718745a ↗
67. Formation of Protein—Metal Oxide Nanostructures by the Sonochemical Method: Observation of Nanofibers and Nanoneedles10.1021/la7013682 ↗
68. Surface Modified Fe3O4 Nanoparticles as a Protein Delivery Vehicle10.1016/j.colsurfa.2009.08.022 ↗
69. Synthesis of Amino-Silane Modified Superparamagnetic Silica Supports and Their Use for Protein Immobilization10.1016/j.colsurfa.2004.03.004 ↗
70. Ojemaye, M.O., and Okoh, A.I. (2019). Multiple Nitrogen Functionalized Magnetic Nanoparticles as an Efficient Adsorbent: Synthesis, Kinetics, Isotherm and Thermodynamic Studies for the Removal of Rhodamine B from Aqueous Solution. Sci. Rep., 9.10.1038/s41598-019-45293-x ↗
71. Photonic Immobilization of BSA for Nanobiomedical Applications: Creation of High Density Microarrays and Superparamagnetic Bioconjugates10.1002/bit.23015 ↗
72. Bychkova, A.V., Yakunina, M.N., Lopukhova, M.V., Degtyarev, Y.N., Motyakin, M.V., Pokrovsky, V.S., Kovarski, A.L., Gorobets, M.G., Retivov, V.M., and Khachatryan, D.S. (2022). Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging. Pharmaceutics, 14.10.3390/pharmaceutics14122771 ↗
73. Study of Protein Coatings Cross Linked via the Free Radical Mechanism on Magnetic Nanoparticles by the Method of Spectral and Fluorescent Probes10.1134/S1061933X14040036 ↗
74. Infrared Spectroscopy of Proteins10.1016/j.bbabio.2007.06.004 ↗
75. Cristian, R.E., Mohammad, I.J., Mernea, M., Sbarcea, B.G., Trica, B., Stan, M.S., and Dinischiotu, A. (2019). Analyzing the Interaction between Two Different Types of Nanoparticles and Serum Albumin. Materials, 19.10.3390/ma12193183 ↗
76. Usoltsev, D., Sitnikova, V., Kajava, A., and Uspenskaya, M. (2019). Systematic FTIR Spectroscopy Study of the Secondary Structure Changes in Human Serum Albumin under Various Denaturation Conditions. Biomolecules, 9.10.3390/biom9080359 ↗
77. Electrostatic Unfolding and Interactions of Albumin Driven by PH Changes: A Molecular Dynamics Study10.1021/jp409936v ↗
78. Time-Dependent PH Scanning of the Acid-Induced Unfolding of Human Serum Albumin Reveals Stabilization of the Native Form by Palmitic Acid Binding10.1021/acs.jpcb.7b01342 ↗
79. Human Serum Albumin Unfolding: A Small-Angle X-Ray Scattering and Light Scattering Study10.1021/jp806821e ↗
80. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in Human Blood Plasma at 0.2, 1.5, and 3 Tesla10.1097/01.rli.0000197668.44926.f7 ↗
81. Insights into Preformed Human Serum Albumin Corona on Iron Oxide Nanoparticles: Structure, Effect of Particle Size, Impact on MRI Efficiency, and Metabolization10.1021/acsabm.9b00386 ↗
82. V Investigating Non-Covalent Interactions of Human Serum Albumin with Doxorubicin and Folic Acid10.1134/S1990750823600413 ↗
83. Doxorubicin Loaded Dual PH- and Thermo-Responsive Magnetic Nanocarrier for Combined Magnetic Hyperthermia and Targeted Controlled Drug Delivery Applications10.1039/C5NR07773G ↗
84. Kinetic Models for the Release of the Anticancer Drug Doxorubicin from Biodegradable Polylactide/Metal Oxide-Based Hybrids10.1016/j.ijbiomac.2014.10.038 ↗
85. Hornsby, T.K., Kashkooli, F.M., Jakhmola, A., Kolios, M.C., and Tavakkoli, J. (2023). Kinetic Modelling of Ultrasound-Triggered Chemotherapeutic Drug Release from the Surface of Gold Nanoparticles. Sci. Rep., 13.10.1038/s41598-023-48082-9 ↗